JWCA has advised PARATEK on capital market transactions with nearly $200 million in transaction value
February 2019: JWCA advises Paratek on its $32.5 million royalty-backed loan with Healthcare Royalty Partners
April 2018: JWCA advises Paratek Pharmaceuticals on its $165 million convertible debt offering